Cargando…
Correction: Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP)
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020839/ https://www.ncbi.nlm.nih.gov/pubmed/27591014 http://dx.doi.org/10.1136/bmjopen-2013-003533corr1 |
Ejemplares similares
-
Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP)
por: Sawada, Hideyuki, et al.
Publicado: (2013) -
Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years
por: Sawada, Hideyuki, et al.
Publicado: (2018) -
Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis
por: Chaudhry, I. B., et al.
Publicado: (2021) -
Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment
por: Diaz‑Galvan, Patricia, et al.
Publicado: (2023) -
Correction to: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
por: Pahwa, Rajesh, et al.
Publicado: (2023)